Utilize este identificador para referenciar este registo:
http://hdl.handle.net/10362/181869| Título: | Equity research report: Johnson & Johnson: a legacy of innovation and steady growth |
| Autor: | Jacob, Justin |
| Orientador: | André, Rosário |
| Palavras-chave: | Drugs Research & Development Valuation Litigations |
| Data de Defesa: | 24-Jan-2025 |
| Resumo: | This equity research report, prepared as part of Nova SBE’s Field Lab by Justin Jacob and Rupert Schuler, evaluates Johnson & Johnson (JNJ). Our valuation estimates a share price of $183, indicating the stock is undervalued compared to its December 13, 2024 market price of $146.62. A detailed relative valuation and sensitivity analysis across four scenarios support this conclusion. The report considers JNJ’s operational resilience, ongoing litigations, and macroeconomic factors, providing a balanced assessment of internal and external influences on the company’s intrinsic value. |
| URI: | http://hdl.handle.net/10362/181869 |
| Designação: | A Work Project, presented as part of the requirements for the Award of a Master Degree in Economics / Finance / Management from the NOVA – School of Business and Economics |
| Aparece nas colecções: | NSBE: Nova SBE - MA Dissertations |
Ficheiros deste registo:
| Ficheiro | Descrição | Tamanho | Formato | |
|---|---|---|---|---|
| FALL25_57984_Justin_Jacob.pdf | 419,97 kB | Adobe PDF | Ver/Abrir |
Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.
